Moderna posts surprise quarterly profit even as COVID sales continue to slide
Moderna on Thursday reported a surprise fourth-quarter profit even as its COVID product sales continue to plunge.
Stay updated with breaking news from Immunizations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Moderna on Thursday reported a surprise fourth-quarter profit even as its COVID product sales continue to plunge.
Novavax reaches a settlement related to an advance purchase agreement with Gavi.
Moderna shares were falling after the biotech revealed data that might hurt its vaccine’s competitive position.
Compared with controls, women with heavy menstrual bleeding were more likely to have received their last dose of mRNA vaccine in the previous 1-3 months in a recent study.
Merck on Thursday reported fourth-quarter earnings and sales that beat analyst expectations, powered by strong growth in cancer and vaccine products.